Tenet Healthcare

Recent news

• Raymond James Initiates Tenet Healthcare(THC.US) With Buy Rating, Announces Target Price $285
  Market Newswire · 2026/9/28
• Rating change
  BofA Securities Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $295
  Market Newswire · 2026/8/10
• Rating change
  A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $263 to $283
  Market Newswire · 2026/7/27
• Rating change
  Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $305
  Market Newswire · 2026/7/30
• BMO Capital Initiates Tenet Healthcare(THC.US) With Hold Rating, Announces Target Price $265
  Market Newswire · 2026/9/23
• Company notice
  The Honest | SC 13G: Statement of acquisition of beneficial ownership by individuals-THC Shared Abacus, LP(13.37%),J. Michael Chu(13.37%), etc.
  SEC · 2022/2/15
• Tenet Healthcare(THC.US) Director Sells US$3.17 Million in Common Stock
  Market Newswire · 2026/9/17
• Rating change
  UBS Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $308
  Market Newswire · 2026/8/25
• Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 3.21 Million in Common Stocks
  Market Newswire · 2026/9/15
• Rating change
  A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $263 to $308
  Market Newswire · 2026/7/28
• Rating change
  J.P. Morgan Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $315
  Market Newswire · 2026/9/2
• Company notice
  TTJ: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Disclosure of THC Venture Pte. Ltd.'s Interest
  SGX · 2022/8/29
• Rating change
  Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $305
  Market Newswire · 2026/7/29
• Leerink Partners Maintains Tenet Healthcare(THC.US) With Buy Rating
  Market Newswire · 2026/9/18
• Rating change
  Mizuho Securities Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $290
  Market Newswire · 2026/8/10
• Rating change
  Morgan Stanley Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $274
  Market Newswire · 2026/9/14
• Company notice
  The Honest | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THC Shared Abacus, LP(0%),J. Michael Chu(0%), etc.
  SEC · 2024/11/15
• Company notice
  TTJ: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Disclosure of THC Venture Pte. Ltd.'s Interest
  SGX · 2022/7/22

Headlines are aggregated automatically and are not independently verified or edited by our team.